{"id":3427,"date":"2026-04-15T23:48:44","date_gmt":"2026-04-15T23:48:44","guid":{"rendered":"https:\/\/psocan.marketaccess.ca\/politique-et-plaidoyer\/contributions-des-patients\/"},"modified":"2026-04-16T20:06:56","modified_gmt":"2026-04-16T20:06:56","slug":"contributions-des-patients","status":"publish","type":"page","link":"https:\/\/psoriasiscanada.ca\/fr\/politique-et-plaidoyer\/contributions-des-patients\/","title":{"rendered":"Contributions des patients"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"3427\" class=\"elementor elementor-3427 elementor-3298\" data-elementor-post-type=\"page\">\n\t\t\t\t<div class=\"elementor-element elementor-element-37676039 e-flex e-con-boxed e-con e-parent\" data-id=\"37676039\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-c9e77b6 elementor-widget elementor-widget-heading\" data-id=\"c9e77b6\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h1 class=\"elementor-heading-title elementor-size-default\">Contributions des patients<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-f910eb7 elementor-widget elementor-widget-text-editor\" data-id=\"f910eb7\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>Lorsqu&#8217;un nouveau m\u00e9dicament contre le psoriasis ou le rhumatisme psoriasique est mis \u00e0 la disposition des patients au Canada, il doit \u00eatre \u00e9valu\u00e9 dans le contexte des autres m\u00e9dicaments disponibles pour ces maladies si le fabricant souhaite qu&#8217;il soit inscrit sur la liste des m\u00e9dicaments rembours\u00e9s par l&#8217;\u00c9tat. Le gouvernement du Qu\u00e9bec dispose de sa propre \u00e9valuation des technologies de la sant\u00e9 (ETS), r\u00e9alis\u00e9e par l&#8217;Institut national d&#8217;excellence en sant\u00e9 et en services sociaux (INESSS). Tous les autres r\u00e9gimes publics d&#8217;assurance-m\u00e9dicaments au Canada se r\u00e9f\u00e8rent \u00e0 l&#8217;ETS r\u00e9alis\u00e9e par l&#8217;Agence canadienne des m\u00e9dicaments (CDA-AMC).  <\/p><p>Dans le cadre de ces processus, les patients sont invit\u00e9s \u00e0 faire part de leur exp\u00e9rience de la maladie, de l&#8217;utilit\u00e9 des traitements existants, de leurs objectifs th\u00e9rapeutiques et de leur exp\u00e9rience du nouveau m\u00e9dicament (s&#8217;ils l&#8217;ont essay\u00e9) ou de leurs attentes \u00e0 son \u00e9gard (s&#8217;ils ne l&#8217;ont pas essay\u00e9). Certaines provinces (Colombie-Britannique, Ontario) ont leur propre processus d&#8217;ETS qui fait appel \u00e0 la participation des patients et des soignants. <\/p><h4>2026<\/h4><p>Prochainement<\/p><h4>2025<\/h4><ul><li><a href=\"https:\/\/psoriasiscanada.ca\/~documents\/route%3A\/download\/10\/\">Roflumilast Foam &#8211; CDA-AMC &#8211; Novembre 2025<\/a><\/li><li><a href=\"https:\/\/psoriasiscanada.ca\/~documents\/route%3A\/download\/11\/\">Tofacitinib dans l&#8217;arthrite juv\u00e9nile idiopathique &#8211; CDA-AMC &#8211; juillet 2025<\/a><\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Contributions des patients Lorsqu&#8217;un nouveau m\u00e9dicament contre le psoriasis ou le rhumatisme psoriasique est mis \u00e0 la disposition des patients au Canada, il doit \u00eatre \u00e9valu\u00e9 dans le contexte des autres m\u00e9dicaments disponibles pour ces maladies si le fabricant souhaite qu&#8217;il soit inscrit sur la liste des m\u00e9dicaments rembours\u00e9s par l&#8217;\u00c9tat. Le gouvernement du Qu\u00e9bec [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":2295,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"website_toolbox_forum_postUrl":"","website_toolbox_forum_category":"","website_toolbox_publish_on_forum":"","footnotes":""},"class_list":["post-3427","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Contributions des patients - Psoriasis Canada<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/psoriasiscanada.ca\/policy-and-advocacy\/patient-input-submissions\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Contributions des patients - Psoriasis Canada\" \/>\n<meta property=\"og:description\" content=\"Contributions des patients Lorsqu&#8217;un nouveau m\u00e9dicament contre le psoriasis ou le rhumatisme psoriasique est mis \u00e0 la disposition des patients au Canada, il doit \u00eatre \u00e9valu\u00e9 dans le contexte des autres m\u00e9dicaments disponibles pour ces maladies si le fabricant souhaite qu&#8217;il soit inscrit sur la liste des m\u00e9dicaments rembours\u00e9s par l&#8217;\u00c9tat. Le gouvernement du Qu\u00e9bec [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/psoriasiscanada.ca\/policy-and-advocacy\/patient-input-submissions\/\" \/>\n<meta property=\"og:site_name\" content=\"Psoriasis Canada\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/PsoriasisCan1\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-16T20:06:56+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/psoriasiscanada.ca\\\/policy-and-advocacy\\\/patient-input-submissions\\\/\",\"url\":\"https:\\\/\\\/psoriasiscanada.ca\\\/policy-and-advocacy\\\/patient-input-submissions\\\/\",\"name\":\"Contributions des patients - Psoriasis Canada\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/psoriasiscanada.ca\\\/#website\"},\"datePublished\":\"2026-04-15T23:48:44+00:00\",\"dateModified\":\"2026-04-16T20:06:56+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/psoriasiscanada.ca\\\/policy-and-advocacy\\\/patient-input-submissions\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/psoriasiscanada.ca\\\/policy-and-advocacy\\\/patient-input-submissions\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/psoriasiscanada.ca\\\/policy-and-advocacy\\\/patient-input-submissions\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/psoriasiscanada.ca\\\/fr\\\/home\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Politique et plaidoyer\",\"item\":\"https:\\\/\\\/psoriasiscanada.ca\\\/policy-and-advocacy\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Contributions des patients\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/psoriasiscanada.ca\\\/#website\",\"url\":\"https:\\\/\\\/psoriasiscanada.ca\\\/\",\"name\":\"Psoriasis Canada\",\"description\":\"Psoriasis Canada\",\"publisher\":{\"@id\":\"https:\\\/\\\/psoriasiscanada.ca\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/psoriasiscanada.ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/psoriasiscanada.ca\\\/#organization\",\"name\":\"Psoriasis Canada\",\"url\":\"https:\\\/\\\/psoriasiscanada.ca\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/psoriasiscanada.ca\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/psoriasiscanada.ca\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/logo.png\",\"contentUrl\":\"https:\\\/\\\/psoriasiscanada.ca\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/logo.png\",\"width\":222,\"height\":73,\"caption\":\"Psoriasis Canada\"},\"image\":{\"@id\":\"https:\\\/\\\/psoriasiscanada.ca\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/PsoriasisCan1\",\"https:\\\/\\\/www.linkedin.com\\\/in\\\/psoriasiscan1\",\"https:\\\/\\\/www.youtube.com\\\/@PsoriasisCan1\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Contributions des patients - Psoriasis Canada","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/psoriasiscanada.ca\/policy-and-advocacy\/patient-input-submissions\/","og_locale":"fr_FR","og_type":"article","og_title":"Contributions des patients - Psoriasis Canada","og_description":"Contributions des patients Lorsqu&#8217;un nouveau m\u00e9dicament contre le psoriasis ou le rhumatisme psoriasique est mis \u00e0 la disposition des patients au Canada, il doit \u00eatre \u00e9valu\u00e9 dans le contexte des autres m\u00e9dicaments disponibles pour ces maladies si le fabricant souhaite qu&#8217;il soit inscrit sur la liste des m\u00e9dicaments rembours\u00e9s par l&#8217;\u00c9tat. Le gouvernement du Qu\u00e9bec [&hellip;]","og_url":"https:\/\/psoriasiscanada.ca\/policy-and-advocacy\/patient-input-submissions\/","og_site_name":"Psoriasis Canada","article_publisher":"https:\/\/www.facebook.com\/PsoriasisCan1","article_modified_time":"2026-04-16T20:06:56+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/psoriasiscanada.ca\/policy-and-advocacy\/patient-input-submissions\/","url":"https:\/\/psoriasiscanada.ca\/policy-and-advocacy\/patient-input-submissions\/","name":"Contributions des patients - Psoriasis Canada","isPartOf":{"@id":"https:\/\/psoriasiscanada.ca\/#website"},"datePublished":"2026-04-15T23:48:44+00:00","dateModified":"2026-04-16T20:06:56+00:00","breadcrumb":{"@id":"https:\/\/psoriasiscanada.ca\/policy-and-advocacy\/patient-input-submissions\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/psoriasiscanada.ca\/policy-and-advocacy\/patient-input-submissions\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/psoriasiscanada.ca\/policy-and-advocacy\/patient-input-submissions\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/psoriasiscanada.ca\/fr\/home\/"},{"@type":"ListItem","position":2,"name":"Politique et plaidoyer","item":"https:\/\/psoriasiscanada.ca\/policy-and-advocacy\/"},{"@type":"ListItem","position":3,"name":"Contributions des patients"}]},{"@type":"WebSite","@id":"https:\/\/psoriasiscanada.ca\/#website","url":"https:\/\/psoriasiscanada.ca\/","name":"Psoriasis Canada","description":"Psoriasis Canada","publisher":{"@id":"https:\/\/psoriasiscanada.ca\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/psoriasiscanada.ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/psoriasiscanada.ca\/#organization","name":"Psoriasis Canada","url":"https:\/\/psoriasiscanada.ca\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/psoriasiscanada.ca\/#\/schema\/logo\/image\/","url":"https:\/\/psoriasiscanada.ca\/wp-content\/uploads\/2025\/11\/logo.png","contentUrl":"https:\/\/psoriasiscanada.ca\/wp-content\/uploads\/2025\/11\/logo.png","width":222,"height":73,"caption":"Psoriasis Canada"},"image":{"@id":"https:\/\/psoriasiscanada.ca\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/PsoriasisCan1","https:\/\/www.linkedin.com\/in\/psoriasiscan1","https:\/\/www.youtube.com\/@PsoriasisCan1"]}]}},"_links":{"self":[{"href":"https:\/\/psoriasiscanada.ca\/fr\/wp-json\/wp\/v2\/pages\/3427","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/psoriasiscanada.ca\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/psoriasiscanada.ca\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/psoriasiscanada.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/psoriasiscanada.ca\/fr\/wp-json\/wp\/v2\/comments?post=3427"}],"version-history":[{"count":1,"href":"https:\/\/psoriasiscanada.ca\/fr\/wp-json\/wp\/v2\/pages\/3427\/revisions"}],"predecessor-version":[{"id":3428,"href":"https:\/\/psoriasiscanada.ca\/fr\/wp-json\/wp\/v2\/pages\/3427\/revisions\/3428"}],"up":[{"embeddable":true,"href":"https:\/\/psoriasiscanada.ca\/fr\/wp-json\/wp\/v2\/pages\/2295"}],"wp:attachment":[{"href":"https:\/\/psoriasiscanada.ca\/fr\/wp-json\/wp\/v2\/media?parent=3427"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}